Woulgan® is a wound care gel containing soluble beta-glucan (SBG®) and is intended for the treatment of complicated wounds such as Diabetic Foot Ulcers and hard to heal wounds.

The soluble beta-glucan (SBG®) in Woulgan® has the ability to modulate the immunological system by activating macrophages in the wound bed to promote rapid wound healing, and has been proven to close wounds faster[1].

Woulgan® is indicated for wounds with low to moderate exudate and its key benefits are:

  • Increased cell proliferation
  • Improved angiogenesis
  • Inhibits excessive protease activity due to its acidic pH
  • Attracts phagocytic cells to the wound bed thereby facilitating wound healing and wound contraction[2]

For further information please visit www.woulgan.com or contact info@hrhealthcare.co.uk


  1. www.clinicaltrials.gov ID number: NCT 00288392, http://biotec.no/beta-glucans/woulgan-biogel
  2. Five model studies using WOULGAN® in wound healing in diabetic mice. Studies performed by a contract research laboratory for Biotec BetaGlucans